Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 20 (2) , 66-71
- https://doi.org/10.1016/s0167-5699(98)01392-9
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- ESCAPE OF HUMAN IMMUNODEFICIENCY VIRUS FROM IMMUNE CONTROLAnnual Review of Immunology, 1997
- Mother-to-Infant Transmission of HIV Type 1: Role of Major Histocompatibility Antigen DifferencesAIDS Research and Human Retroviruses, 1996
- Allostimulated Lymphocytes Inhibit Replication of HIV Type 1AIDS Research and Human Retroviruses, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Immunization with class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIVmac-32HAIDS, 1995
- Alloimmunization as an AIDS Vaccine?Science, 1993
- Does the HIV envelope induce a chronic graft-versus-host-like disease?Immunology Today, 1992
- Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infectionEuropean Journal of Immunology, 1991
- Nonrandom association of cellular antigens with HTLV-III virionsHuman Immunology, 1987
- Selective incorporation of H–2 antigenic determinants into Friend virus particlesNature, 1977